Dexcom (DXCM) Amortizatization of Intangibles (2010 - 2021)
Dexcom's (DXCM) quarterly Amortizatization of Intangibles came in at $22.0 million in Q3 2021, up 1.38% year-over-year from $21.7 million in Q3 2020, and down 2.22% quarter-over-quarter from $22.5 million in Q2 2021.
Analysis
Dexcom (DXCM) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends
Dexcom (DXCM) has reported Amortizatization of Intangibles for 12 consecutive years, with $22.0 million the latest figure, recorded in Q3 2021.
- On a quarterly basis, Amortizatization of Intangibles rose 1.38% year-over-year to $22.0 million in Q3 2021; TTM through Sep 2021 was $88.4 million, a 36.84% increase from a year earlier, with the FY2019 full-year figure at $49.6 million, up 177.09% from the prior year.
- Amortizatization of Intangibles was $22.0 million for Q3 2021 at Dexcom, down from $22.5 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $22.5 million in Q2 2021 and troughed at $100000.0 in Q1 2017.
- A 5-year average of $10.3 million and a median of $8.0 million in 2019 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 3600.0% in 2018 and increased 1.38% in 2021, its largest moves.
- Over 5 years, Amortizatization of Intangibles stood at $3.7 million in 2017, then soared by 78.38% to $6.6 million in 2018, then surged by 90.91% to $12.6 million in 2019, then jumped by 72.22% to $21.7 million in 2020, then rose by 1.38% to $22.0 million in 2021.
- The last three Amortizatization of Intangibles figures came in at $22.0 million (Q3 2021), $22.5 million (Q2 2021), and $22.2 million (Q1 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 178.06 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.21 Bn | 101.73 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.61 Bn | 66.07 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.47 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | - |
| 9 | Steris | 21.09 Bn | 20.61 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.18 Bn | 17.77 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 22.50 Mn |
| Mar 31, 2021 | 22.20 Mn |
| Sep 30, 2020 | 21.70 Mn |
| Jun 30, 2020 | 17.60 Mn |
| Mar 31, 2020 | 12.70 Mn |
| Dec 31, 2019 | 12.60 Mn |
| Sep 30, 2019 | 8.00 Mn |
| Jun 30, 2019 | 7.90 Mn |
| Mar 31, 2019 | 12.20 Mn |
| Dec 31, 2018 | 6.60 Mn |
| Sep 30, 2018 | 3.40 Mn |
| Jun 30, 2018 | 3.30 Mn |
| Mar 31, 2018 | 3.70 Mn |
| Dec 31, 2017 | 3.70 Mn |
| Sep 30, 2017 | 3.10 Mn |
| Jun 30, 2017 | 1.80 Mn |
| Mar 31, 2017 | 100,000.00 |
| Sep 30, 2016 | 100,000.00 |
| Jun 30, 2016 | 100,000.00 |